Selected research
Industry Research
Aurora Kinase A Industry Research Report 2026
Market perspective
The global Aurora Kinase A market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Aurora Kinase A is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Aurora Kinase A is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Aurora Kinase A is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Aurora Kinase A include Sanofi, Merck & Co., Inc., Amgen Inc., AbbVie Inc., Vichem Chemie Research Ltd., Vertex Pharmaceuticals Incorporated, Taiho Pharmaceutical Co., Ltd., Sigma-Tau S.p.A. and Sareum Holdings Plc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Aurora Kinase A market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Aurora Kinase A Market by Company
Sanofi
Merck & Co., Inc.
Amgen Inc.
AbbVie Inc.
Vichem Chemie Research Ltd.
Vertex Pharmaceuticals Incorporated
Taiho Pharmaceutical Co., Ltd.
Sigma-Tau S.p.A.
Sareum Holdings Plc
Millennium Pharmaceuticals, Inc.
CASI Pharmaceuticals Inc.
Astex Pharmaceuticals, Inc.
Aurora Kinase A Segment by Type
AMG-900
Ilorasertib
ENMD-2076
Danusertib
Others
Aurora Kinase A Segment by Application
Brain Tumor
Ovarian Cancer
Anaplastic Large Cell Lymphoma
Others
Aurora Kinase A Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Aurora Kinase A market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Aurora Kinase A and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Aurora Kinase A.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Aurora Kinase A manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Aurora Kinase A by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Aurora Kinase A in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- AMG-900
- Ilorasertib
- ENMD-2076
- Danusertib
- Others
Applications
- Brain Tumor
- Ovarian Cancer
- Anaplastic Large Cell Lymphoma
- Others
Companies covered
- Sanofi
- Merck & Co., Inc.
- Amgen Inc.
- AbbVie Inc.
- Vichem Chemie Research Ltd.
- Vertex Pharmaceuticals Incorporated
- Taiho Pharmaceutical Co., Ltd.
- Sigma-Tau S.p.A.
- Sareum Holdings Plc
- Millennium Pharmaceuticals, Inc.
- CASI Pharmaceuticals Inc.
- Astex Pharmaceuticals, Inc.
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Aurora Kinase A Market Size (2021-2032)
- 2.2.2 Global Aurora Kinase A Sales (2021-2032)
- 2.2.3 Global Aurora Kinase A Market Average Price (2021-2032)
- 2.3 Aurora Kinase A by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 AMG-900
- 2.3.3 Ilorasertib
- 2.3.4 ENMD-2076
- 2.3.5 Danusertib
- 2.3.6 Others
- 2.4 Aurora Kinase A by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Brain Tumor
- 2.4.3 Ovarian Cancer
- 2.4.4 Anaplastic Large Cell Lymphoma
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Aurora Kinase A Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Aurora Kinase A Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Aurora Kinase A Revenue of Manufacturers (2021-2026)
- 3.4 Global Aurora Kinase A Average Price by Manufacturers (2021-2026)
- 3.5 Global Aurora Kinase A Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Aurora Kinase A, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Aurora Kinase A, Product Type & Application
- 3.8 Global Manufacturers of Aurora Kinase A, Established Date
- 3.9 Global Aurora Kinase A Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Sanofi
- 4.1.1 Sanofi Company Information
- 4.1.2 Sanofi Business Overview
- 4.1.3 Sanofi Aurora Kinase A Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Sanofi Aurora Kinase A Product Portfolio
- 4.1.5 Sanofi Recent Developments
- 4.2 Merck & Co., Inc.
- 4.2.1 Merck & Co., Inc. Company Information
- 4.2.2 Merck & Co., Inc. Business Overview
- 4.2.3 Merck & Co., Inc. Aurora Kinase A Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Merck & Co., Inc. Aurora Kinase A Product Portfolio
- 4.2.5 Merck & Co., Inc. Recent Developments
- 4.3 Amgen Inc.
- 4.3.1 Amgen Inc. Company Information
- 4.3.2 Amgen Inc. Business Overview
- 4.3.3 Amgen Inc. Aurora Kinase A Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Amgen Inc. Aurora Kinase A Product Portfolio
- 4.3.5 Amgen Inc. Recent Developments
- 4.4 AbbVie Inc.
- 4.4.1 AbbVie Inc. Company Information
- 4.4.2 AbbVie Inc. Business Overview
- 4.4.3 AbbVie Inc. Aurora Kinase A Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 AbbVie Inc. Aurora Kinase A Product Portfolio
- 4.4.5 AbbVie Inc. Recent Developments
- 4.5 Vichem Chemie Research Ltd.
- 4.5.1 Vichem Chemie Research Ltd. Company Information
- 4.5.2 Vichem Chemie Research Ltd. Business Overview
- 4.5.3 Vichem Chemie Research Ltd. Aurora Kinase A Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Vichem Chemie Research Ltd. Aurora Kinase A Product Portfolio
- 4.5.5 Vichem Chemie Research Ltd. Recent Developments
- 4.6 Vertex Pharmaceuticals Incorporated
- 4.6.1 Vertex Pharmaceuticals Incorporated Company Information
- 4.6.2 Vertex Pharmaceuticals Incorporated Business Overview
- 4.6.3 Vertex Pharmaceuticals Incorporated Aurora Kinase A Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Vertex Pharmaceuticals Incorporated Aurora Kinase A Product Portfolio
- 4.6.5 Vertex Pharmaceuticals Incorporated Recent Developments
- 4.7 Taiho Pharmaceutical Co., Ltd.
- 4.7.1 Taiho Pharmaceutical Co., Ltd. Company Information
- 4.7.2 Taiho Pharmaceutical Co., Ltd. Business Overview
- 4.7.3 Taiho Pharmaceutical Co., Ltd. Aurora Kinase A Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Taiho Pharmaceutical Co., Ltd. Aurora Kinase A Product Portfolio
- 4.7.5 Taiho Pharmaceutical Co., Ltd. Recent Developments
- 4.8 Sigma-Tau S.p.A.
- 4.8.1 Sigma-Tau S.p.A. Company Information
- 4.8.2 Sigma-Tau S.p.A. Business Overview
- 4.8.3 Sigma-Tau S.p.A. Aurora Kinase A Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Sigma-Tau S.p.A. Aurora Kinase A Product Portfolio
- 4.8.5 Sigma-Tau S.p.A. Recent Developments
- 4.9 Sareum Holdings Plc
- 4.9.1 Sareum Holdings Plc Company Information
- 4.9.2 Sareum Holdings Plc Business Overview
- 4.9.3 Sareum Holdings Plc Aurora Kinase A Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Sareum Holdings Plc Aurora Kinase A Product Portfolio
- 4.9.5 Sareum Holdings Plc Recent Developments
- 4.10 Millennium Pharmaceuticals, Inc.
- 4.10.1 Millennium Pharmaceuticals, Inc. Company Information
- 4.10.2 Millennium Pharmaceuticals, Inc. Business Overview
- 4.10.3 Millennium Pharmaceuticals, Inc. Aurora Kinase A Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Millennium Pharmaceuticals, Inc. Aurora Kinase A Product Portfolio
- 4.10.5 Millennium Pharmaceuticals, Inc. Recent Developments
- 4.11 CASI Pharmaceuticals Inc.
- 4.11.1 CASI Pharmaceuticals Inc. Company Information
- 4.11.2 CASI Pharmaceuticals Inc. Business Overview
- 4.11.3 CASI Pharmaceuticals Inc. Aurora Kinase A Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 CASI Pharmaceuticals Inc. Aurora Kinase A Product Portfolio
- 4.11.5 CASI Pharmaceuticals Inc. Recent Developments
- 4.12 Astex Pharmaceuticals, Inc.
- 4.12.1 Astex Pharmaceuticals, Inc. Company Information
- 4.12.2 Astex Pharmaceuticals, Inc. Business Overview
- 4.12.3 Astex Pharmaceuticals, Inc. Aurora Kinase A Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Astex Pharmaceuticals, Inc. Aurora Kinase A Product Portfolio
- 4.12.5 Astex Pharmaceuticals, Inc. Recent Developments
5 Global Aurora Kinase A Market Scenario by Region
- 5.1 Global Aurora Kinase A Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Aurora Kinase A Sales by Region: 2021-2032
- 5.2.1 Global Aurora Kinase A Sales by Region: 2021-2026
- 5.2.2 Global Aurora Kinase A Sales by Region: 2027-2032
- 5.3 Global Aurora Kinase A Revenue by Region: 2021-2032
- 5.3.1 Global Aurora Kinase A Revenue by Region: 2021-2026
- 5.3.2 Global Aurora Kinase A Revenue by Region: 2027-2032
- 5.4 North America Aurora Kinase A Market Facts & Figures by Country
- 5.4.1 North America Aurora Kinase A Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Aurora Kinase A Sales by Country (2021-2032)
- 5.4.3 North America Aurora Kinase A Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Aurora Kinase A Market Facts & Figures by Country
- 5.5.1 Europe Aurora Kinase A Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Aurora Kinase A Sales by Country (2021-2032)
- 5.5.3 Europe Aurora Kinase A Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Aurora Kinase A Market Facts & Figures by Country
- 5.6.1 Asia Pacific Aurora Kinase A Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Aurora Kinase A Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Aurora Kinase A Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Aurora Kinase A Market Facts & Figures by Country
- 5.7.1 South America Aurora Kinase A Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Aurora Kinase A Sales by Country (2021-2032)
- 5.7.3 South America Aurora Kinase A Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Aurora Kinase A Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Aurora Kinase A Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Aurora Kinase A Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Aurora Kinase A Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Aurora Kinase A Sales by Type (2021-2032)
- 6.1.1 Global Aurora Kinase A Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Aurora Kinase A Sales Market Share by Type (2021-2032)
- 6.2 Global Aurora Kinase A Revenue by Type (2021-2032)
- 6.2.1 Global Aurora Kinase A Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Aurora Kinase A Revenue Market Share by Type (2021-2032)
- 6.3 Global Aurora Kinase A Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Aurora Kinase A Sales by Application (2021-2032)
- 7.1.1 Global Aurora Kinase A Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Aurora Kinase A Sales Market Share by Application (2021-2032)
- 7.2 Global Aurora Kinase A Revenue by Application (2021-2032)
- 7.2.1 Global Aurora Kinase A Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Aurora Kinase A Revenue Market Share by Application (2021-2032)
- 7.3 Global Aurora Kinase A Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Aurora Kinase A Value Chain Analysis
- 8.1.1 Aurora Kinase A Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Aurora Kinase A Production Mode & Process
- 8.2 Aurora Kinase A Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Aurora Kinase A Distributors
- 8.2.3 Aurora Kinase A Customers
9 Global Aurora Kinase A Analyzing Market Dynamics
- 9.1 Aurora Kinase A Industry Trends
- 9.2 Aurora Kinase A Industry Drivers
- 9.3 Aurora Kinase A Industry Opportunities and Challenges
- 9.4 Aurora Kinase A Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst